Fundamentals data is not available for this company.
No recent information was found.
| Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
| Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Currency | US Dollars |
| Share Price | $ 28.49 |
| Change Today | $ -0.03 |
| % Change | -0.11 % |
| 52 Week High | $36.00 |
| 52 Week Low | $26.13 |
| Volume | 760,113 |
| Shares Issued | 156.88m |
| Market Cap | $4,469.58m |
| RiskGrade | 248 |
| Time | Volume / Share Price |
| 15:59 | 120 @ $28.49 |
| 15:59 | 100 @ $28.49 |
| 15:59 | 100 @ $28.48 |
| 15:59 | 200 @ $28.49 |
| 15:59 | 100 @ $28.49 |
You are here: research